THOMAS FRANK E — SEC insider filings

SEC reporting owner CIK 1242616. 29 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 29 filings on record, filed 2020-09-30 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Larimar Therapeutics, Inc. (LRMR)Director103 legs · 15,000 sh · $68,800—7
Orchard Therapeutics plc (ORTX)See Remarks101 leg · 10,000 sh · $7,474—40
Spero Therapeutics, Inc. (SPRO)Director9——10

Insider filings — THOMAS FRANK E

FiledFormIssuerReported transactionsSource
2026-11-124Larimar Therapeutics, Inc. (LRMR)Purchase (P): 8,000 @ $2.73EDGAR
2026-06-254Spero Therapeutics, Inc. (SPRO)Grant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2026-05-204Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 55,150 (derivative) @ $0EDGAR
2026-03-024Larimar Therapeutics, Inc. (LRMR)Purchase (P): 5,000 @ $5EDGAR
2025-06-164Spero Therapeutics, Inc. (SPRO)Grant/award (A): 20,000 @ $0EDGAR
2025-05-144Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2024-05-314Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2024-05-304Spero Therapeutics, Inc. (SPRO)Grant/award (A): 20,000 @ $0EDGAR
2024-02-154Larimar Therapeutics, Inc. (LRMR)Purchase (P): 2,000 @ $11EDGAR
2024-01-244Orchard Therapeutics plc (ORTX)Disposition to issuer (D): 92,081 · Disposition to issuer (D): 99,980 (derivative) @ $0 · Disposition to issuer (D): 199,990 (derivative) @ $0 · Disposition to issuer (D): 149,990 (derivative) @ $0 · Disposition to issuer (D): 309,990 (derivative) @ $0 · Disposition to issuer (D): 27,730 (derivative) @ $0 · +5 moreEDGAR
2023-10-104Spero Therapeutics, Inc. (SPRO)Grant/award (A): 20,000 @ $0EDGAR
2023-05-114Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 8,300 (derivative) @ $0EDGAR
2023-03-144Orchard Therapeutics plc (ORTX)Option exercise (M): 20,000 @ $0.46 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2023-03-034Orchard Therapeutics plc (ORTX)Grant/award (A): 405,600 (derivative) @ $0 · Grant/award (A): 179,400 (derivative) @ $0EDGAR
2023-02-134Orchard Therapeutics plc (ORTX)Option exercise (M): 20,000 @ $0.46 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2022-10-064Orchard Therapeutics plc (ORTX)Disposition to issuer (D): 426,185 (derivative) @ $0 · Grant/award (A): 426,185 (derivative) @ $0 · Disposition to issuer (D): 184,229 (derivative) @ $0 · Grant/award (A): 184,229 (derivative) @ $0 · Disposition to issuer (D): 100,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 · +10 moreEDGAR
2022-09-194Spero Therapeutics, Inc. (SPRO)Grant/award (A): 15,000 @ $0EDGAR
2022-06-034Orchard Therapeutics plc (ORTX)Grant/award (A): 375,000 (derivative) @ $0EDGAR
2022-05-124Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 8,300 (derivative) @ $0EDGAR
2022-04-044Orchard Therapeutics plc (ORTX)Purchase (P): 10,000 @ $0.75EDGAR
2022-01-074Spero Therapeutics, Inc. (SPRO)Grant/award (A): 2,214 (derivative) @ $9.03EDGAR
2021-08-184Spero Therapeutics, Inc. (SPRO)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2021-05-174Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 8,300 (derivative) @ $0EDGAR
2021-02-034Orchard Therapeutics plc (ORTX)Grant/award (A): 27,731 (derivative) @ $0 · Grant/award (A): 310,000 (derivative) @ $0EDGAR
2021-02-014Orchard Therapeutics plc (ORTX)Option exercise (M): 10,000 @ $2.44 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-01-124Orchard Therapeutics plc (ORTX)Grant/award (A): 10,667 @ $0 · Tax withholding (F): 3,706 @ $6.72EDGAR
2021-01-064Spero Therapeutics, Inc. (SPRO)Grant/award (A): 1,314 (derivative) @ $13.31EDGAR
2020-10-274Spero Therapeutics, Inc. (SPRO)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2020-09-304Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 16,600 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1242616 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs